Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | SPRY ARS Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 12.3113 | 50,000 | 615.57 k | 210,346 |
3 Feb 25 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 4.85 | 40,936 | 198.54 k | 260,346 |
3 Feb 25 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 3.15 | 9,064 | 28.55 k | 219,410 |
3 Feb 25 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 4.85 | 40,936 | 198.54 k | 124,064 |
3 Feb 25 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.15 | 9,064 | 28.55 k | 0 |
6 Jan 25 | SPRY ARS Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 11.1013 | 50,000 | 555.07 k | 210,346 |
6 Jan 25 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 3.15 | 50,000 | 157.50 k | 260,346 |
6 Jan 25 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.15 | 50,000 | 157.50 k | 9,064 |
4 Dec 24 | SPRY ARS Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 13.7496 | 14,772 | 203.11 k | 210,346 |
4 Dec 24 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 3.15 | 14,772 | 46.53 k | 225,118 |